Omega-3 Polyunsaturated Fatty Acid Supplementation Reduced Atrial Fibrillation Recurrence after Pulmonary Vein Antrum Isolation

Objective: To assess if patients treated with omega-3(n-3) polyunsaturated fatty acids (PUFAS) had lower procedural failure rates compared to an untreated population.Methods and Results: From January 2004 to 2007, 1500 PVAI patients underwent catheter ablation. Two hundred and eighty five (19%) pati...

Full description

Bibliographic Details
Main Authors: Dimpi Patel, Mazen Shaheen, Preeti Venkatraman, Luciana Armaganijan, Javier E Sanchez, Rodney P Horton, Luigi Di Biase, Prasant Mohanty, Robert Canby, Shane M Bailey, J David Burkhardt, G Joesph Gallinghouse, Jason D Zagrodzky, Marketa Kozeluhova, Andrea Natale
Format: Article
Language:English
Published: Elsevier 2009-11-01
Series:Indian Pacing and Electrophysiology Journal
Subjects:
Online Access:http://www.ipej.org/0906/patel.htm
id doaj-d51d278278924219a6fb83a3dbf4547c
record_format Article
spelling doaj-d51d278278924219a6fb83a3dbf4547c2020-11-25T00:27:40ZengElsevierIndian Pacing and Electrophysiology Journal0972-62922009-11-0196292298Omega-3 Polyunsaturated Fatty Acid Supplementation Reduced Atrial Fibrillation Recurrence after Pulmonary Vein Antrum IsolationDimpi PatelMazen ShaheenPreeti VenkatramanLuciana ArmaganijanJavier E SanchezRodney P HortonLuigi Di BiasePrasant MohantyRobert CanbyRobert CanbyShane M BaileyJ David BurkhardtG Joesph GallinghouseJason D ZagrodzkyMarketa KozeluhovaAndrea NataleObjective: To assess if patients treated with omega-3(n-3) polyunsaturated fatty acids (PUFAS) had lower procedural failure rates compared to an untreated population.Methods and Results: From January 2004 to 2007, 1500 PVAI patients underwent catheter ablation. Two hundred and eighty five (19%) patients were treated with PUFAs. These patients were matched in a nested case controlled analysis. After matching, there were 129 patients in the PUFA group and 129 in the control group. Thirty-five (27.1%) patients in the study group had early recurrence vs. 57 (44.1%) in the control group p-value<0.0001. Twenty-nine (23.2%) patients in the PUFA group vs. 41 (31.7%) in the non-PUFA group had procedural failure (p-value <0.003). There were no significant differences in complications in the PUFA and non-PUFA groups.Conclusion: Patients treated with PUFAs had lower incidences of early recurrence and procedural failure compared to an untreated population. http://www.ipej.org/0906/patel.htmPolyunsaturated Fatty acids (PUFA)Atrial Fibrillation (AF)Pulmonary vein isolation (PVAI)
collection DOAJ
language English
format Article
sources DOAJ
author Dimpi Patel
Mazen Shaheen
Preeti Venkatraman
Luciana Armaganijan
Javier E Sanchez
Rodney P Horton
Luigi Di Biase
Prasant Mohanty
Robert Canby
Robert Canby
Shane M Bailey
J David Burkhardt
G Joesph Gallinghouse
Jason D Zagrodzky
Marketa Kozeluhova
Andrea Natale
spellingShingle Dimpi Patel
Mazen Shaheen
Preeti Venkatraman
Luciana Armaganijan
Javier E Sanchez
Rodney P Horton
Luigi Di Biase
Prasant Mohanty
Robert Canby
Robert Canby
Shane M Bailey
J David Burkhardt
G Joesph Gallinghouse
Jason D Zagrodzky
Marketa Kozeluhova
Andrea Natale
Omega-3 Polyunsaturated Fatty Acid Supplementation Reduced Atrial Fibrillation Recurrence after Pulmonary Vein Antrum Isolation
Indian Pacing and Electrophysiology Journal
Polyunsaturated Fatty acids (PUFA)
Atrial Fibrillation (AF)
Pulmonary vein isolation (PVAI)
author_facet Dimpi Patel
Mazen Shaheen
Preeti Venkatraman
Luciana Armaganijan
Javier E Sanchez
Rodney P Horton
Luigi Di Biase
Prasant Mohanty
Robert Canby
Robert Canby
Shane M Bailey
J David Burkhardt
G Joesph Gallinghouse
Jason D Zagrodzky
Marketa Kozeluhova
Andrea Natale
author_sort Dimpi Patel
title Omega-3 Polyunsaturated Fatty Acid Supplementation Reduced Atrial Fibrillation Recurrence after Pulmonary Vein Antrum Isolation
title_short Omega-3 Polyunsaturated Fatty Acid Supplementation Reduced Atrial Fibrillation Recurrence after Pulmonary Vein Antrum Isolation
title_full Omega-3 Polyunsaturated Fatty Acid Supplementation Reduced Atrial Fibrillation Recurrence after Pulmonary Vein Antrum Isolation
title_fullStr Omega-3 Polyunsaturated Fatty Acid Supplementation Reduced Atrial Fibrillation Recurrence after Pulmonary Vein Antrum Isolation
title_full_unstemmed Omega-3 Polyunsaturated Fatty Acid Supplementation Reduced Atrial Fibrillation Recurrence after Pulmonary Vein Antrum Isolation
title_sort omega-3 polyunsaturated fatty acid supplementation reduced atrial fibrillation recurrence after pulmonary vein antrum isolation
publisher Elsevier
series Indian Pacing and Electrophysiology Journal
issn 0972-6292
publishDate 2009-11-01
description Objective: To assess if patients treated with omega-3(n-3) polyunsaturated fatty acids (PUFAS) had lower procedural failure rates compared to an untreated population.Methods and Results: From January 2004 to 2007, 1500 PVAI patients underwent catheter ablation. Two hundred and eighty five (19%) patients were treated with PUFAs. These patients were matched in a nested case controlled analysis. After matching, there were 129 patients in the PUFA group and 129 in the control group. Thirty-five (27.1%) patients in the study group had early recurrence vs. 57 (44.1%) in the control group p-value<0.0001. Twenty-nine (23.2%) patients in the PUFA group vs. 41 (31.7%) in the non-PUFA group had procedural failure (p-value <0.003). There were no significant differences in complications in the PUFA and non-PUFA groups.Conclusion: Patients treated with PUFAs had lower incidences of early recurrence and procedural failure compared to an untreated population.
topic Polyunsaturated Fatty acids (PUFA)
Atrial Fibrillation (AF)
Pulmonary vein isolation (PVAI)
url http://www.ipej.org/0906/patel.htm
work_keys_str_mv AT dimpipatel omega3polyunsaturatedfattyacidsupplementationreducedatrialfibrillationrecurrenceafterpulmonaryveinantrumisolation
AT mazenshaheen omega3polyunsaturatedfattyacidsupplementationreducedatrialfibrillationrecurrenceafterpulmonaryveinantrumisolation
AT preetivenkatraman omega3polyunsaturatedfattyacidsupplementationreducedatrialfibrillationrecurrenceafterpulmonaryveinantrumisolation
AT lucianaarmaganijan omega3polyunsaturatedfattyacidsupplementationreducedatrialfibrillationrecurrenceafterpulmonaryveinantrumisolation
AT javieresanchez omega3polyunsaturatedfattyacidsupplementationreducedatrialfibrillationrecurrenceafterpulmonaryveinantrumisolation
AT rodneyphorton omega3polyunsaturatedfattyacidsupplementationreducedatrialfibrillationrecurrenceafterpulmonaryveinantrumisolation
AT luigidibiase omega3polyunsaturatedfattyacidsupplementationreducedatrialfibrillationrecurrenceafterpulmonaryveinantrumisolation
AT prasantmohanty omega3polyunsaturatedfattyacidsupplementationreducedatrialfibrillationrecurrenceafterpulmonaryveinantrumisolation
AT robertcanby omega3polyunsaturatedfattyacidsupplementationreducedatrialfibrillationrecurrenceafterpulmonaryveinantrumisolation
AT robertcanby omega3polyunsaturatedfattyacidsupplementationreducedatrialfibrillationrecurrenceafterpulmonaryveinantrumisolation
AT shanembailey omega3polyunsaturatedfattyacidsupplementationreducedatrialfibrillationrecurrenceafterpulmonaryveinantrumisolation
AT jdavidburkhardt omega3polyunsaturatedfattyacidsupplementationreducedatrialfibrillationrecurrenceafterpulmonaryveinantrumisolation
AT gjoesphgallinghouse omega3polyunsaturatedfattyacidsupplementationreducedatrialfibrillationrecurrenceafterpulmonaryveinantrumisolation
AT jasondzagrodzky omega3polyunsaturatedfattyacidsupplementationreducedatrialfibrillationrecurrenceafterpulmonaryveinantrumisolation
AT marketakozeluhova omega3polyunsaturatedfattyacidsupplementationreducedatrialfibrillationrecurrenceafterpulmonaryveinantrumisolation
AT andreanatale omega3polyunsaturatedfattyacidsupplementationreducedatrialfibrillationrecurrenceafterpulmonaryveinantrumisolation
_version_ 1725338465551253504